Spectral studies on the molecular interaction of anticancer drug mitoxantrone with CTAB micelles.

The interaction of anticancer drug mitoxantrone with cationic surfactant cetyltrimethylammonium bromide (CTAB) has been investigated by absorption spectroscopy as a function of surfactant concentration ranging from the premicellar to postmicellar region at pH 7.4 and 10. Interaction of mitoxantrone with CTAB micelles induces a bathochromic shift of both absorption maxima and spectral data showed that the micellization reduces the dimerization process and mitoxantrone is bound into micelles in the monomeric form.

Coupled spectral and electrochemical evaluation of the anticancer drug mitoxantrone-sodium dodecyl sulfate interaction.

In-vitro evaluation of the interaction of anticancer drug mitoxantrone with anionic surfactant sodium dodecyl sulfate (SDS), was performed in physiological conditions (phosphate buffer, pH 7.4) by spectral (UV-vis absorption) and electrochemical (cyclic and linear voltammetry) methods. The stoichiometry of interaction, the binding constants and diffusion coefficients of free and bound drug were determined.

Spectroelectrochemistry of the redox activation of anti-cancer drug mitoxantrone.

The redox behaviour of the anti-cancer drug mitoxantrone was investigated in aprotic media (dimethylsulfoxide-DMSO) by coupled electrochemical and spectral EPR and UV/VIS absorption techniques. The cyclic voltammetry study with stationary and rotating disc electrode (RDE) of the reductive pathway of mitoxantrone points to two-electron transfers and evidences as intermediate species the anion radical, the dianion and the corresponding protonated species. EPR and optical spectra registered during the electrochemical reduction allow the identification of these species and suggest the possibility of back oxidation of the drug by electron transfer to molecular oxygen.